A Hypoxia and EMT-Related Gene Signature for Predicting Prognosis and Immunotherapy Benefit in Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma · 2026-10 · Volume 13 · 1-18
DOI: 10.2147/jhc.s642054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-10. Verfasst von Wenhao Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, Zhengzhou Central Hospital Affiliated with Zhengzhou University, Zhengzhou, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency, Zhengzhou Central Hospital Affiliated with Zhengzhou University, Zhengzhou, People's Republic of China.
- Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.
- Key Laboratory of Precision Diagnosis and Treatment in General Surgical (Hepatobiliary and Pancreatic) Diseases of Health Commission of Henan Province, Zhengzhou, People's Republic of China.
- Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.
Zitieren
APA
Hu, W., Gao, D., Hou, G., Liu, C., Meng, X., Liu, Q., & Sun, J. (2026). A Hypoxia and EMT-Related Gene Signature for Predicting Prognosis and Immunotherapy Benefit in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, Volume 13, 1-18. https://doi.org/10.2147/jhc.s642054
Vancouver
Hu W, Gao D, Hou G, Liu C, Meng X, Liu Q, et al. A Hypoxia and EMT-Related Gene Signature for Predicting Prognosis and Immunotherapy Benefit in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-18. doi:10.2147/jhc.s642054
BibTeX
@article{Hu2026,
author = {Hu, Wenhao and Gao, Dute and Hou, Guojun and Liu, Chang and Meng, Xianglong and Liu, Qinlong and Sun, Jiaan},
title = {A Hypoxia and EMT-Related Gene Signature for Predicting Prognosis and Immunotherapy Benefit in Hepatocellular Carcinoma},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--18},
doi = {10.2147/jhc.s642054}
}
EUVIMED